Skip to main content
. 2017 May 17;8(46):80286–80294. doi: 10.18632/oncotarget.17925

Table 1. Characteristics of the study patients (n = 50).

Subset No. of patients (%)
[Median (range) age in years 67 (44–78)]
Sex Male 45 (90)
Female 5 (10)
Smoking status Never 3 (6)
Smoker 47 (94)
ECOG performance status 0–1 46 (92)
2–3 4 (8)
Tumor histology Squamous cell carcinoma 48 (96)
Adenocarcinoma 2 (4)
Tumor location Cervical 3 (6)
Upper thoracic 12 (24)
Middle thoracic 20 (40)
Lower thoracic 14 (28)
Abdominal 1 (2)
T stage T1 0 (0)
T2 1 (2)
T3 32 (64)
T4a/T4b 3 (6)/14 (28)
N stage N0 1 (2)
N1 28 (56)
N2 8 (16)
N3 13 (26)
Metastasis sites Lymph nodes 40
Liver 19
Lung 19
Bone 13
Adrenal gland 3
Kidney 1
Peritoneum 1
Pleura 2
[Median (range) tumor length (cm) 6 (3–20)]
Dysphagia score 0 (asymptomatic) 1 (2)
1 (eat solid diet with some dysphagia) 9 (18)
2 (eat semisolid diet) 28 (56)
3 (drink liquid diet) 8 (16)
4 (complete dysphagia) 4 (8)
Chemotherapy regimen 5-FU + cisplatin 43 (86)
5-FU + nedaplatin 6 (12)
5-FU alone 1 (2)
Total radiation dose (Gy) 54 2 (4)
50 43 (86)
< 50 5 (10)